Statistics for The BETRI study : preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G)
Total visits
| views | |
|---|---|
| The BETRI study : preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G) | 5 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 2 |
| October 2025 | 2 |
| November 2025 | 0 |
| December 2025 | 1 |
File Visits
| views | |
|---|---|
| Price_etal_ATS_The_BETRI_Study_AAM.pdf | 60 |